{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:00:22Z","timestamp":1792789222802,"version":"4.5.0"},"reference-count":94,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82460541"],"award-info":[{"award-number":["82460541"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China","award":["82160590"],"award-info":[{"award-number":["82160590"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"award":["82460541"],"award-info":[{"award-number":["82460541"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"award":["82160590"],"award-info":[{"award-number":["82160590"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>The OVO-like (OVOL) proteins OVOL1\u20133 are evolutionarily conserved C2H2 zinc-finger transcription factors. Initially identified in Drosophila as regulators of germline development, these proteins have since been found to be key determinants of epithelial lineage and differentiation in mammals. Increasing evidence implicates OVOL proteins in human disease, particularly cancer, where they participate in diverse processes including metastasis, metabolic regulation, immunity, and inflammation modulation. In this review, current advances in OVOL-related research are summarized. First, the roles of OVOL proteins in regulating epithelial\u2013mesenchymal transition (EMT), cancer metastasis, and cellular plasticity are addressed. The discussion then extends to emerging evidence for their involvement in metabolic reprogramming, immunity, and inflammation. Finally, open questions and future research directions are discussed.<\/jats:p>","DOI":"10.3390\/cells15191755","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T08:18:46Z","timestamp":1790583526000},"page":"1755","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["OVO-like Proteins in Cancer, Immunity, and Inflammation"],"prefix":"10.3390","volume":"15","author":[{"given":"Shuxian","family":"Huang","sequence":"first","affiliation":[{"name":"Guangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin 541199, China"},{"name":"Guangxi Health Commission Key Laboratory of Tumor Immunology and Receptor-Targeted Drug Basic Research, Guilin Medical University, Guilin 541199, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genjian","family":"Hu","sequence":"additional","affiliation":[{"name":"Guangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin 541199, China"},{"name":"Guangxi Health Commission Key Laboratory of Tumor Immunology and Receptor-Targeted Drug Basic Research, Guilin Medical University, Guilin 541199, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3555-0279","authenticated-orcid":false,"given":"Hao","family":"Lan","sequence":"additional","affiliation":[{"name":"Guangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin 541199, China"},{"name":"Guangxi Health Commission Key Laboratory of Tumor Immunology and Receptor-Targeted Drug Basic Research, Guilin Medical University, Guilin 541199, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Gan","sequence":"additional","affiliation":[{"name":"Guangxi Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin 541199, China"},{"name":"Guangxi Health Commission Key Laboratory of Tumor Immunology and Receptor-Targeted Drug Basic Research, Guilin Medical University, Guilin 541199, China"},{"name":"Department of Immunology, College of Basic Medicine, Guilin Medical University, Guilin 541199, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000511383","article-title":"OVOL1\/2: Drivers of Epithelial Differentiation in Development, Disease, and Reprogramming","volume":"211","author":"Saxena","year":"2022","journal-title":"Cells Tissues Organs"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.tcb.2023.05.008","article-title":"OVOL2: An epithelial lineage determiner with emerging roles in energy homeostasis","volume":"33","author":"Jiang","year":"2023","journal-title":"Trends Cell Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jdermsci.2018.02.005","article-title":"The role of the OVOL1-OVOL2 axis in normal and diseased human skin","volume":"90","author":"Tsuji","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.stemcr.2018.12.008","article-title":"OVOL1 Influences the Determination and Expansion of iPSC Reprogramming Intermediates","volume":"12","author":"Kagawa","year":"2019","journal-title":"Stem Cell Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"7786","DOI":"10.1038\/s41467-023-43456-z","article-title":"OVOL2 sustains postnatal thymic epithelial cell identity","volume":"14","author":"Zhong","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Patterson, V.S., Jeyarajah, M.J., Rampersaud, A.M., Bhattad, G.J., and Renaud, S.J. (2026). OVOL2 Reinforces Epithelial Identity and Promotes SynT-I Differentiation in the Mouse Placenta. Biol. Reprod., Online ahead of print.","DOI":"10.1093\/biolre\/ioag157"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"15436","DOI":"10.18632\/oncotarget.3623","article-title":"OVOL guides the epithelial-hybrid-mesenchymal transition","volume":"6","author":"Jia","year":"2015","journal-title":"Oncotarget"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"112628","DOI":"10.1016\/j.cellsig.2026.112628","article-title":"OVOL1 targets YAP to suppress esophageal squamous cell carcinoma progression","volume":"146","author":"Yan","year":"2026","journal-title":"Cell Signal."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1053\/j.gastro.2015.11.041","article-title":"OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors","volume":"150","author":"Ye","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e177840","DOI":"10.1172\/jci.insight.177840","article-title":"Targeting ketone body metabolism in mitigating gemcitabine resistance","volume":"9","author":"You","year":"2024","journal-title":"JCI Insight"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.imlet.2021.05.004","article-title":"OVOL2 inhibits macrophage M2 polarization by regulating IL-10 transcription, and thus inhibits the tumor metastasis by modulating the tumor microenvironment","volume":"242","author":"Wu","year":"2022","journal-title":"Immunol. Lett."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"27417","DOI":"10.1038\/s41598-025-13196-9","article-title":"Unveiling the impact of OVOL1 on prognosis, immune microenvironment, and proliferation in pancreatic cancer","volume":"15","author":"Li","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3892\/ol.2023.13765","article-title":"Comprehensive analysis of the expression, prognostic value and biological importance of OVO-like proteins in clear cell renal cell carcinoma","volume":"25","author":"Lin","year":"2023","journal-title":"Oncol. Lett."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/imm.13120","article-title":"The IL-13-OVOL1-FLG axis in atopic dermatitis","volume":"158","author":"Furue","year":"2019","journal-title":"Immunology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e204687","DOI":"10.1172\/jci.insight.204687","article-title":"IL-13 and calpain-14 suppress the expression of SPINK7 by regulating OVOL1 in eosinophilic esophagitis","volume":"11","author":"Azouz","year":"2026","journal-title":"JCI Insight"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s41571-025-01058-2","article-title":"EMT and cancer: What clinicians should know","volume":"22","author":"Thompson","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12943-023-01793-z","article-title":"EMT\/MET plasticity in cancer and Go-or-Grow decisions in quiescence: The two sides of the same coin?","volume":"22","author":"Akhmetkaliyev","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Imodoye, S.O., Adedokun, K.A., Muhammed, A.O., Bello, I.O., Muhibi, M.A., Oduola, T., and Oyenike, M.A. (2021). Understanding the Complex Milieu of Epithelial-Mesenchymal Transition in Cancer Metastasis: New Insight Into the Roles of Transcription Factors. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.762817"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Peng, F., Fan, H., Li, S., Peng, C., and Pan, X. (2021). MicroRNAs in Epithelial-Mesenchymal Transition Process of Cancer: Potential Targets for Chemotherapy. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147526"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"15032","DOI":"10.1038\/s41598-026-44905-7","article-title":"Mesenchymal to epithelial transition (MET) in cancer progression: Insights from logical modeling","volume":"16","author":"Ruscone","year":"2026","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"EMBR201846273","DOI":"10.15252\/embr.201846273","article-title":"An Ovol2-Zeb1 transcriptional circuit regulates epithelial directional migration and proliferation","volume":"20","author":"Haensel","year":"2019","journal-title":"EMBO Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/cac2.12138","article-title":"EMT-associated microRNAs and their roles in cancer stemness and drug resistance","volume":"41","author":"Pan","year":"2021","journal-title":"Cancer Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11538-024-01277-1","article-title":"Combinatorial Cooperativity in miR200-Zeb Feedback Network can Control Epithelial-Mesenchymal Transition","volume":"86","author":"Rashid","year":"2024","journal-title":"Bull. Math. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1002\/mco2.659","article-title":"Epithelial-mesenchymal plasticity in cancer: Signaling pathways and therapeutic targets","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm (2020)"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Kobayashi, N., Kajita, Y., Yang, F., Fukuda, N., Somekawa, K., Kaneko, A., and Katakura, S. (2025). The miR-200 Family in Non-Small-Cell Lung Cancer: Molecular Mechanisms, Clinical Applications, and Therapeutic Implications. Genes, 16.","DOI":"10.3390\/genes16111312"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cell.2013.06.005","article-title":"Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity","volume":"154","author":"Chaffer","year":"2013","journal-title":"Cell"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Roca, H., Hernandez, J., Weidner, S., McEachin, R.C., Fuller, D., Sud, S., Schumann, T., Wilkinson, J.E., Zaslavsky, A., and Li, H. (2013). Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076773"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.devcel.2014.03.005","article-title":"Transcriptional mechanisms link epithelial plasticity to adhesion and differentiation of epidermal progenitor cells","volume":"29","author":"Lee","year":"2014","journal-title":"Dev. Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.devcel.2014.03.006","article-title":"Mammary morphogenesis and regeneration require the inhibition of EMT at terminal end buds by Ovol2 transcriptional repressor","volume":"29","author":"Watanabe","year":"2014","journal-title":"Dev. Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.7150\/thno.24003","article-title":"OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma","volume":"8","author":"Qi","year":"2018","journal-title":"Theranostics"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"110240","DOI":"10.1016\/j.celrep.2021.110240","article-title":"Coordinate control of basal epithelial cell fate and stem cell maintenance by core EMT transcription factor Zeb1","volume":"38","author":"Han","year":"2022","journal-title":"Cell Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e108647","DOI":"10.15252\/embj.2021108647","article-title":"Dynamic EMT: A multi-tool for tumor progression","volume":"40","author":"Brabletz","year":"2021","journal-title":"EMBO J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1016\/j.devcel.2021.11.012","article-title":"Partial EMT takes the lead in cancer metastasis","volume":"56","author":"Haerinck","year":"2021","journal-title":"Dev. Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12943-026-02690-x","article-title":"Hallmarks of epithelial-mesenchymal plasticity in cancer","volume":"25","author":"Clauzon","year":"2026","journal-title":"Mol. Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Hong, T., Watanabe, K., Ta, C.H., Villarreal-Ponce, A., Nie, Q., and Dai, X. (2015). An Ovol2-Zeb1 Mutual Inhibitory Circuit Governs Bidirectional and Multi-step Transition between Epithelial and Mesenchymal States. PLoS Comput. Biol., 11.","DOI":"10.1371\/journal.pcbi.1004569"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Rashid, M., Hari, K., Thampi, J., Santhosh, N.K., and Jolly, M.K. (2022). Network topology metrics explaining enrichment of hybrid epithelial\/mesenchymal phenotypes in metastasis. PLoS Comput. Biol., 18.","DOI":"10.1101\/2022.05.16.492000"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13619-024-00207-9","article-title":"TGFbeta family signaling in human stem cell self-renewal and differentiation","volume":"13","author":"Liu","year":"2024","journal-title":"Cell Regen."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2023.10.004","article-title":"TGF-beta, EMT, and resistance to anti-cancer treatment","volume":"97","author":"Wang","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s43556-026-00403-w","article-title":"TGF-beta in tumor development and progression: Mechanisms and therapeutics","volume":"7","author":"Liu","year":"2026","journal-title":"Mol. Biomed."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41392-022-00944-w","article-title":"OVOL1 inhibits breast cancer cell invasion by enhancing the degradation of TGF-\u03b2 type I receptor","volume":"7","author":"Fan","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_42","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","article-title":"Generic Diagramming Platform (GDP): A comprehensive database of high-quality biomedical graphics","volume":"53","author":"Jiang","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.trecan.2022.04.007","article-title":"Cellular and molecular mechanisms of plasticity in cancer","volume":"8","author":"Torborg","year":"2022","journal-title":"Trends Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"eado3473","DOI":"10.1126\/scisignal.ado3473","article-title":"Re-epithelialization of cancer cells increases autophagy and DNA damage: Implications for breast cancer dormancy and relapse","volume":"18","author":"Giri","year":"2025","journal-title":"Sci. Signal."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e23552","DOI":"10.1002\/dvg.23552","article-title":"Tumor dormancy: EMT beyond invasion and metastasis","volume":"62","author":"Aouad","year":"2024","journal-title":"Genesis"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jhep.2026.01.018","article-title":"The changing epidemiology of primary liver cancer in the 21(st) century","volume":"85","author":"Khan","year":"2026","journal-title":"J. Hepatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"102447","DOI":"10.1016\/j.coph.2024.102447","article-title":"Targeting TRP channels for pain relief: A review of current evidence from bench to bedside","volume":"75","author":"Koivisto","year":"2024","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13046-025-03495-4","article-title":"TRP channels and cancer modulation: A voyage beyond metabolic reprogramming, oxidative stress and the advent of nanotechnologies in targeted therapy","volume":"44","author":"Giannaccari","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"109270","DOI":"10.1016\/j.biopha.2019.109270","article-title":"Targeting TRPV1 on cellular plasticity regulated by Ovol 2 and Zeb 1 in hepatocellular carcinoma","volume":"118","author":"Xie","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_51","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12943-023-01839-2","article-title":"Mechanisms of radiotherapy resistance and radiosensitization strategies for esophageal squamous cell carcinoma","volume":"22","author":"An","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.7150\/thno.82690","article-title":"Nasopharyngeal carcinoma ecology theory: Cancer as multidimensional spatiotemporal \u201cunity of ecology and evolution\u201d pathological ecosystem","volume":"13","author":"Luo","year":"2023","journal-title":"Theranostics"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Qin, W., Hu, W., and Geng, Y. (2025). The Function and Mechanism of OXCT1 in Tumor Progression as a Critical Ketone Body Metabolic Enzyme. Biomolecules, 16.","DOI":"10.3390\/biom16010004"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Lorito, N., Bonechi, F., Romano, E., Smiriglia, A., and Morandi, A. (2026). Under pressure: Peroxisomes in cancer therapy resistance. Trends Mol. Med., Online ahead of print.","DOI":"10.1016\/j.molmed.2026.05.001"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMra1708701","article-title":"Update on Keratinocyte Carcinomas","volume":"379","author":"Nehal","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hoc.2018.08.001","article-title":"Cutaneous Squamous Cell Carcinoma","volume":"33","author":"Waldman","year":"2019","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/ijd.16164","article-title":"The risk of metastases from squamous cell carcinoma of the skin","volume":"62","author":"Caudill","year":"2023","journal-title":"Int. J. Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"adv00266","DOI":"10.2340\/00015555-3628","article-title":"Risk Factors and Prognosis for Metastatic Cutaneous Squamous Cell Carcinoma: A Cohort Study","volume":"100","author":"Knuutila","year":"2020","journal-title":"Acta Derm. Venereol."},{"key":"ref_60","first-page":"166","article-title":"Preferential expression of OVOL1 in inner root sheath of hair, sebaceous gland, eccrine duct and their neoplasms in human skin","volume":"105","author":"Mitoma","year":"2014","journal-title":"Fukuoka Igaku Zasshi"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.ajpath.2015.12.013","article-title":"Activation of the OVOL1-OVOL2 Axis in the Hair Bulb and in Pilomatricoma","volume":"186","author":"Ito","year":"2016","journal-title":"Am. J. Pathol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/modpathol.2016.169","article-title":"Potential role of the OVOL1-OVOL2 axis and c-Myc in the progression of cutaneous squamous cell carcinoma","volume":"30","author":"Ito","year":"2017","journal-title":"Mod. Pathol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.oraloncology.2013.03.440","article-title":"Anaplastic thyroid cancer","volume":"49","author":"Shaha","year":"2013","journal-title":"Oral Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13046-022-02316-2","article-title":"OVOL2 impairs RHO GTPase signaling to restrain mitosis and aggressiveness of Anaplastic Thyroid Cancer","volume":"41","author":"Gugnoni","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s42003-026-10601-5","article-title":"A bioenergetic understanding of \u201caerobic glycolysis\u201d","volume":"9","author":"Wasem","year":"2026","journal-title":"Commun. Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12964-022-00845-z","article-title":"An NF-\u03baB\/OVOL2 circuit regulates glucose import and cell survival in non-small cell lung cancer","volume":"20","author":"Zhang","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"101491","DOI":"10.1016\/j.gendis.2024.101491","article-title":"Emerging roles for fatty acid oxidation in cancer","volume":"12","author":"Ma","year":"2025","journal-title":"Genes Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e2308945","DOI":"10.1002\/advs.202308945","article-title":"Loss of OVOL2 in Triple-Negative Breast Cancer Promotes Fatty Acid Oxidation Fueling Stemness Characteristics","volume":"11","author":"Lu","year":"2024","journal-title":"Adv. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/s41401-025-01531-9","article-title":"Targeting cholesterol metabolism: A promising therapy strategy for cancer","volume":"46","author":"Dai","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e70634","DOI":"10.1111\/jcmm.70634","article-title":"OVOL1 Promotes Proliferation and Metastasis of Non-Small Cell Lung Cancer by Regulating APOE-Mediated Cholesterol Metabolism","volume":"29","author":"Feng","year":"2025","journal-title":"J. Cell. Mol. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-immunol-082323-030832","article-title":"Barrier Integrity and Immunity: Exploring the Cutaneous Front Line in Health and Disease","volume":"43","author":"Fukuda","year":"2025","journal-title":"Annu. Rev. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e56214","DOI":"10.15252\/embr.202256214","article-title":"Ovol1\/2 loss-induced epidermal defects elicit skin immune activation and alter global metabolism","volume":"24","author":"Dragan","year":"2023","journal-title":"EMBO Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/all.70061","article-title":"Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions","volume":"81","author":"Boesjes","year":"2026","journal-title":"Allergy"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/1346-8138.13392","article-title":"Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016","volume":"43","author":"Saeki","year":"2016","journal-title":"J. Dermatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s13555-025-01352-y","article-title":"Interleukin-4 and Atopic Dermatitis: Why Does it Matter? A Narrative Review","volume":"15","author":"Torres","year":"2025","journal-title":"Dermatol. Ther."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Sroka-Tomaszewska, J., and Trzeciak, M. (2021). Molecular Mechanisms of Atopic Dermatitis Pathogenesis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22084130"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"020501","DOI":"10.11613\/BM.2019.020501","article-title":"Filaggrin and atopic march","volume":"29","author":"Cepelak","year":"2019","journal-title":"Biochem. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e2931","DOI":"10.1038\/cddis.2017.322","article-title":"Aryl hydrocarbon receptor activation restores filaggrin expression via OVOL1 in atopic dermatitis","volume":"8","author":"Tsuji","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Pappa, G., Sgouros, D., Theodoropoulos, K., Kanelleas, A., Bozi, E., Gregoriou, S., Krasagakis, K., and Katoulis, A.C. (2022). The IL-4\/-13 Axis and Its Blocking in the Treatment of Atopic Dermatitis. J. Clin. Med., 11.","DOI":"10.3390\/jcm11195633"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Ulzii, D., Kido-Nakahara, M., Nakahara, T., Tsuji, G., Furue, K., Hashimoto-Hachiya, A., and Furue, M. (2019). Scratching Counteracts IL-13 Signaling by Upregulating the Decoy Receptor IL-13Ralpha2 in Keratinocytes. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20133324"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.2147\/JIR.S467327","article-title":"Preclinical Models of Atopic Dermatitis Suitable for Mechanistic and Therapeutic Investigations","volume":"17","author":"Maskey","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Lee, E., Min, K., Ahn, H., Jeon, B.N., Park, S., Yun, C., Jeon, H., Yeon, J.S., Kim, H., and Park, H. (2022). Potential Therapeutic Skin Microbiomes Suppressing Staphylococcus aureus-Derived Immune Responses and Upregulating Skin Barrier Function-Related Genes via the AhR Signaling Pathway. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23179551"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1001\/jama.2021.14920","article-title":"Eosinophilic Esophagitis: A Review","volume":"326","author":"Muir","year":"2021","journal-title":"JAMA"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaci.2018.05.008","article-title":"Epithelial origin of eosinophilic esophagitis","volume":"142","author":"Rochman","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2016.11.034","article-title":"Ovol2 gene inhibits the Epithelial-to-Mesenchymal Transition in lung adenocarcinoma by transcriptionally repressing Twist1","volume":"600","author":"Wang","year":"2017","journal-title":"Gene"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"108873","DOI":"10.1016\/j.isci.2024.108873","article-title":"OVOL2 induces autophagy-mediated epithelial-mesenchymal transition by the ERK1\/2 MAPK signaling in lung adenocarcinoma","volume":"27","author":"Wang","year":"2024","journal-title":"iScience"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"153493","DOI":"10.1016\/j.prp.2021.153493","article-title":"OVOL2 attenuates the expression of MAP3K8 to suppress epithelial mesenchymal transition in colorectal cancer","volume":"224","author":"Xia","year":"2021","journal-title":"Pathol. Res. Pract."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.2147\/OTT.S110409","article-title":"Expression of Ovol2 is related to epithelial characteristics and shows a favorable clinical outcome in hepatocellular carcinoma","volume":"9","author":"Fu","year":"2016","journal-title":"Onco Targets Ther."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"39401","DOI":"10.18632\/oncotarget.17031","article-title":"OVOL2 antagonizes TGF-beta signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasis","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Wouters, J., Vizoso, M., Martinez-Cardus, A., Carmona, F.J., Govaere, O., Laguna, T., Joseph, J., Dynoodt, P., Aura, C., and Foth, M. (2017). Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma. BMC Med., 15.","DOI":"10.1186\/s12916-017-0851-3"},{"key":"ref_91","first-page":"e94331","article-title":"Ovo-Like Transcriptional Repressor 1 (OVOL1) Expression in Pleomorphic Adenoma and Carcinoma Ex Pleomorphic Adenoma: Diagnostic and Prognostic Insights","volume":"17","author":"Mohamed","year":"2025","journal-title":"Cureus"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jtcme.2025.04.002","article-title":"Geniposide activates the transcription of Ndufs8 and enhances PD-L1 blockade for inhibiting growth of osteosarcoma","volume":"16","author":"Zheng","year":"2026","journal-title":"J. Tradit. Complement. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1006\/geno.2002.6831","article-title":"Ovol2, a mammalian homolog of Drosophila ovo: Gene structure, chromosomal mapping, and aberrant expression in blind-sterile mice","volume":"80","author":"Li","year":"2002","journal-title":"Genomics"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1038\/s41598-017-04099-5","article-title":"Transcriptome analyses of taste organoids reveal multiple pathways involved in taste cell generation","volume":"7","author":"Ren","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/19\/1755\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:33:58Z","timestamp":1790757238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/19\/1755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,26]]},"references-count":94,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["cells15191755"],"URL":"https:\/\/doi.org\/10.3390\/cells15191755","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,26]]}}}